Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference

Core Insights - Aclaris Therapeutics, Inc. will present at the H.C. Wainwright Inflammation & Immunology Virtual Conference on June 30, 2025, at 11:30 AM EDT [1] - A live and archived webcast of the presentation will be available on the Aclaris website for at least 30 days [2] - Aclaris is focused on developing novel product candidates for immuno-inflammatory diseases, addressing unmet patient needs [3] Company Overview - Aclaris Therapeutics is a clinical-stage biopharmaceutical company with a robust R&D engine and a multi-stage portfolio of product candidates [3] - The company aims to provide treatment options for patients with immuno-inflammatory diseases who currently lack satisfactory therapies [3]